Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Mar;16(5):e70036.
doi: 10.1111/1759-7714.70036.

Chylothorax After Thoracic Surgery: How We Manage It

Affiliations
Case Reports

Chylothorax After Thoracic Surgery: How We Manage It

Alberto Busetto et al. Thorac Cancer. 2025 Mar.

Abstract

Chylothorax is a rare but insidious condition, characterized by the accumulation of chyle in the pleural space, which is particularly common after cardiothoracic surgeries. It presents significant challenges in both diagnosis and treatment. In this technical report, we present our experience in managing four cases of postsurgical chylothorax, each one treated with a different approach. The first and second cases were successfully managed with Lipiodol lymphangiography, which allowed for the visualization and occlusion of the injured lymphatic duct, leading to the resolution of the chylothorax. The third case involved thoracic duct embolization, a procedure that resulted in the closure of the duct responsible for the chylous effusion. The last case involved a patient who developed left-sided chylothorax following a pulmonary resection. The patient experienced chylous leakage early in the postoperative period and underwent a revision thoracoscopy for hemostasis and thoracic duct ligation. During the procedure, indocyanine green (ICG) fluorescence was used to effectively identify and ligate the injured chylous duct. This case series highlights the variety of therapeutic strategies available for the management of chylothorax, emphasizing the importance of a structured, stepwise approach tailored to the specific needs of each patient.

Keywords: chylothorax; indocyanine green fluorescence; lymphangiography; lymphatic embolization; thoracic surgery.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Evidence of contrast agent accumulation in the left pleural cavity and along the lymphatic chain from the inguinal lymph nodes, as detected through a chest CT scan.
FIGURE 2
FIGURE 2
Attempt to embolize the thoracic duct while ascending the opacified abdominal lymphatic system through percutaneous access.
FIGURE 3
FIGURE 3
ICG‐fluorescence highlighting the leakage site in the left subcarinal space, along with the metal clips used to close it.
FIGURE 4
FIGURE 4
Diagnostic and therapeutic flowchart used for the management of chylothorax in our Thoracic Surgery Unit.

References

    1. McGrath E. E., Blades Z., and Anderson P. B., “Chylothorax: Aetiology, Diagnosis and Therapeutic Options,” Respiratory Medicine 104 (2010): 1–8. - PubMed
    1. Agrawal A., Chaddha U., Kaul V., Desai A., Gillaspie E., and Maldonado F., “Multidisciplinary Management of Chylothorax,” Chest 162 (2022): 1402–1412. - PubMed
    1. Martucci N., Tracey M., and Rocco G., “Postoperative Chylothorax,” Thoracic Surgery Clinics 25 (2015): 523–528. - PubMed
    1. Nair S. K., Petko M., and Hayward M. P., “Aetiology and Management of Chylothorax in Adults,” European Journal of Cardio‐Thoracic Surgery 32 (2007): 362–369. - PubMed
    1. Londero F., Grossi W., Vecchiato M., et al., “Fluorescence‐Guided Identification of the Thoracic Duct by VATS for Treatment of Postoperative Chylothorax: A Short Case Series,” Frontiers in Surgery 9 (2022): 912351. - PMC - PubMed

Publication types